PMID: 8943900Dec 1, 1996Paper

Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance

British Journal of Haematology
H A LiebmanW McGehee

Abstract

Resistance to the anticoagulant effects of activated protein C (APC) is now considered the most prevalent cause of inherited thrombophilia. The great majority of patients with activated protein C resistance (APCR) have a missense mutation in the factor V molecule (factor V Leiden, FVR506Q) resulting in defective inactivation of factor Va due to a loss of an APC cleavage site. The diagnosis of APCR has been based upon the inability of APC to prolong the activated partial thromboplastin (aPTT) clotting time in subjects with APCR. However, this assay has a number of deficiencies which limit its general use. We have evaluated a newly described one-stage tissue factor dependent factor V coagulation assay for APCR in 117 patients and controls and compared the results of this assay in a blinded manner to a polymerase chain reaction (PCR) based assay for the molecular defect of factor V Leiden. 43% (50/117) of the patients studied were receiving coumadin or heparin, or had a lupus anticoagulant. The tissue factor dependent factor V assay had 100% specificity and sensitivity for factor V Leiden and successfully predicted a homozygous state in the three documented homozygotes. The PCR-based assay for factor V Leiden resulted in a single ...Continue Reading

Citations

Dec 13, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Holger KirstenPeter Ahnert
Jun 15, 1997·Thrombosis Research·L PredaE Rossi
Dec 31, 1998·Thrombosis Research·L I PatrushevE S Severin
May 6, 1998·Pediatric Neurology·P N VarelasL R Ment
Mar 21, 1998·British Journal of Haematology·K P CrookstonW L Chandler
Aug 25, 1999·British Journal of Haematology·J T WildeN Navot
Feb 16, 2000·Obstetrical & Gynecological Survey·R B Gherman, T M Goodwin
Oct 8, 2003·Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology·Kathleen MurphyKarin Berg
Aug 12, 2009·Clinics in Laboratory Medicine·Bernard Khor, Elizabeth M Van Cott
Jan 23, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Tzu-Yue ShiuTsai-Yuan Hsieh
Feb 18, 2010·American Journal of Hematology·Elizabeth M Van Cott
Jan 29, 1999·Hematology/oncology Clinics of North America·E M Van Cott, M Laposata
Jun 28, 2000·American Journal of Obstetrics and Gynecology·M J FassettD A Wing
Mar 12, 2003·Hematology/oncology Clinics of North America·Gerry A F Nicolaes, Björn Dahlbäck
Jul 13, 2004·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·N SayinalpA Gürgey
May 20, 2014·American Journal of Clinical Pathology·Ming-Tseh LinJames R Eshleman
May 18, 2007·Journal of Clinical Laboratory Analysis·Fei-Liang WongB Othaman Ainoon
Jun 25, 2005·Clinical Chemistry·Annalisa VerriVittorio Grazioli
Aug 26, 1998·European Journal of Haematology·P GiordanoD De Mattia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.